Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults

Clinical trial NCT03619616 · COMPLETED

Trial details

NCT number: NCT03619616
Sponsor: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis(IPF)Solid Tumor

Start date: 2018-07-16
Primary completion: 2019-06-28
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.